Medicare Enrolled
Dr. Gary Cecchi, M.D.
Hematology & Oncology · Vancouver, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cecchi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cecchi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cecchi
Dr. Gary Cecchi is a hematology & oncology specialist in Vancouver, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cecchi performed 560 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cecchi received a total of $11,057 from 66 pharmaceutical and/or device companies across 557 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cecchi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 48% volume in WA
$11,057 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗560
Medicare services
Top 48% in WA for hematology & oncology
Not available
Unique patients (not deduplicated)
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $83 | $134 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $56 | $93 |
| New patient office visit, complex (60-74 min) | 51 | $147 | $378 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
39 | $94 | $331 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $120 | $182 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $114 | $299 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
15 | $81 | $101 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,057
Total received (2018-2024)
Avg $1,580/year across 7 years
Top 20% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
557
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,760
2023
$1,454
2022
$294
2021
$918
2020
$302
2019
$2,660
2018
$3,670
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$417
E.R. Squibb & Sons, L.L.C.
$332
PFIZER INC.
$218
Daiichi Sankyo Inc.
$117
Regeneron Healthcare Solutions, Inc.
$98
Novartis Pharmaceuticals Corporation
$77
Takeda Pharmaceuticals U.S.A., Inc.
$69
Ipsen Biopharmaceuticals, Inc
$51
Incyte Corporation
$45
Celgene Corporation
$43
JAZZ PHARMACEUTICALS INC.
$37
Lilly USA, LLC
$33
Merck Sharp & Dohme LLC
$27
GENZYME CORPORATION
$25
ABBVIE INC.
$24
Genentech USA, Inc.
$23
TerSera Therapeutics LLC
$21
Janssen Biotech, Inc.
$18
Coherus Biosciences Inc.
$18
Myriad Genetic Laboratories, Inc.
$18
GlaxoSmithKline, LLC.
$17
SOBI, INC
$17
Eisai Inc.
$15
Top 3 companies account for 54.9% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,189
AstraZeneca Pharmaceuticals LP
$966
Janssen Biotech, Inc.
$897
Novartis Pharmaceuticals Corporation
$765
PFIZER INC.
$662
Genentech USA, Inc.
$500
Amgen Inc.
$488
Takeda Pharmaceuticals U.S.A., Inc.
$452
Daiichi Sankyo Inc.
$344
Merck Sharp & Dohme Corporation
$288
Celgene Corporation
$249
Bayer HealthCare Pharmaceuticals Inc.
$249
Exelixis Inc.
$247
TESARO, Inc.
$245
Regeneron Healthcare Solutions, Inc.
$235
Octapharma USA, Inc.
$194
GENZYME CORPORATION
$175
Stemline Therapeutics Inc.
$174
Pharmacyclics LLC, An AbbVie Company
$172
Astellas Pharma US Inc
$165
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Incyte Corporation
$151
Lilly USA, LLC
$140
GlaxoSmithKline, LLC.
$128
AbbVie, Inc.
$127
Karyopharm Therapeutics Inc.
$124
Ipsen Biopharmaceuticals, Inc
$121
Gilead Sciences, Inc.
$117
Seagen Inc.
$106
Clovis Oncology, Inc.
$105
JAZZ PHARMACEUTICALS INC.
$74
SOBI, INC
$67
SERVIER PHARMACEUTICALS LLC
$67
Merck Sharp & Dohme LLC
$58
AbbVie Inc.
$56
TerSera Therapeutics LLC
$54
Rigel Pharmaceuticals, Inc.
$48
Bayer Healthcare Pharmaceuticals Inc.
$46
Dendreon Pharmaceuticals LLC
$46
Otsuka America Pharmaceutical, Inc.
$41
Alexion Pharmaceuticals, Inc.
$41
Coherus Biosciences Inc.
$38
Eisai Inc.
$32
EMD Serono, Inc.
$31
EISAI INC.
$30
Taiho Oncology, Inc.
$29
Lexicon Pharmaceuticals, Inc.
$24
AMAG Pharmaceuticals, Inc.
$24
ABBVIE INC.
$24
Foundation Medicine, Inc.
$23
Agios Pharmaceuticals, Inc.
$23
PharmaEssentia USA Corporation
$21
TAIHO ONCOLOGY, INC.
$21
Jazz Pharmaceuticals Inc.
$20
PORTOLA PHARMACEUTICALS, INC.
$20
Myriad Genetic Laboratories, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$18
ARRAY BIOPHARMA INC
$17
Dova Pharmaceuticals
$17
Sirtex Medical Inc
$17
INSYS Therapeutics Inc
$17
BTG International, Inc.
$17
Endo Pharmaceuticals Inc.
$15
Epizyme, Inc.,
$14
Emmaus Medical, Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 27.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Aranesp · BENDEKA · BENLYSTA · BESREMI · BEVYXXA · BOSULIF · BRAFTOVI · Balversa · Blincyto · CABLIVI · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ERLEADA · EXKIVITY · Endari · Enhertu · Erleada · FASLODEX · FERAHEME · FOUNDATIONONE · Fabhalta · GAZYVA · GILOTRIF · HEMLIBRA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LEQVIO · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · MYRISK · NASCOBAL · NINLARO · Neulasta · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · Phesgo · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rituxan Hycela · Rubraca · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VELCADE · VENCLEXTA · VERZENIO · VORAXAZE · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
100
County median income
$94,948
Nearest hospital to ZIP centroid (approximate)
PEACEHEALTH SOUTHWEST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cecchi is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cecchi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cecchi performed 362 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cecchi receive payments from pharmaceutical companies?
Yes. Dr. Cecchi received a total of $11,057 from 66 companies across 557 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cecchi's costs compare to other hematology & oncology specialists in Vancouver?
Dr. Cecchi's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cecchi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Vancouver
Browse hematology & oncology specialists in Vancouver ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in WA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in WA
Which WA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology